NCT06057233View on ClinicalTrials.gov

Innovative MRI to Localize the Epileptic Zone

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Epilepsy, Temporal Lobe
Interventions
DIAGNOSTIC_TEST

mqMRI and GABA-MRS

multiparametric quantitative MRI (mqMRI) and of GABA-edited magnetic resonance spectroscopy (GABA-MRS)

All Listed Sponsors
collaborator

University Grenoble Alps

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Grenoble

OTHER

NCT06057233 - Innovative MRI to Localize the Epileptic Zone | Biotech Hunter | Biotech Hunter